Free shipping on orders over $150  |  All products third-party tested for 99%+ purity Shop Now

Glp 1 Single Dose Vials New Option

Brand-name GLP-1 manufacturers have introduced single-dose vials as a new way to access their medications. This GLP-1 single dose vials affordable resource covers the essential information you need to make informed decisions.

By Dr. Sarah Mitchell, MD, FACE|Reviewed by Dr. James Chen, PharmD|
In This Article

Key Takeaway

Brand-name GLP-1 manufacturers have introduced single-dose vials as a new way to access their medications. This GLP-1 single dose vials affordable resource covers the essential information you need to make informed decisions.

Brand-name GLP-1 manufacturers have introduced single-dose vials as a new way to access their medications. This GLP-1 single dose vials affordable resource covers the essential information you need to make informed decisions. GLP-1 single-dose vials aim to be more affordable than pre-filled pen injectors while still offering the brand-name product. This development adds another option to an already complex pricing field.

Key Takeaways: - Understand what are single-dose vials - Pricing and Availability - Vials vs. Pens vs. Compounded: Practical Differences - Who Benefits Most from Single-Dose Vials

If you are weighing your options for GLP-1 access, single-dose vials deserve a spot in your comparison. They sit between full-price pens and compounded alternatives. Understanding the pricing, availability, and practical differences helps you make the best choice for your situation.

What Are Single-Dose Vials?

Traditional brand-name GLP-1 medications come primarily in pre-filled pen injectors. These pens contain multiple doses and include the delivery device. Single-dose vials are a different format: a small glass vial containing one dose of medication that you draw into a syringe yourself.

Both Novo Nordisk and Eli Lilly have explored vial-based options as part of their efforts to expand access and address affordability concerns. The vial format removes the cost of the pen delivery device, which contributes to the overall product price.

With a single-dose vial, you receive one vial per injection. For weekly GLP-1 medications, that means 4 to 5 vials per month. You need your own syringes and needles, which are inexpensive and widely available at pharmacies.

The medication inside the vial is the same formulation as what comes in the pen. The active ingredient, concentration, and quality are identical. The difference is purely in the delivery method and packaging.

This format is familiar to anyone who has experience with peptide injections or compounded medications. Drawing from a vial into a syringe is a straightforward process. If you are new to this, our covers syringe basics that apply here too.

"GLP-1 receptor agonists represent the most significant advance in obesity pharmacotherapy in decades. For the first time, we have medications that produce weight loss approaching what was previously only achievable through bariatric surgery.") Dr. Robert Kushner, MD, Northwestern University, speaking at ObesityWeek 2023


Free Download: Cost Comparison Spreadsheet A side-by-side comparison of GLP-1 pens vs. Single-dose vials vs. Compounded medications including monthly costs, what is included, and practical differences. Get yours free (we'll email it to you instantly.

[Download Now]


Pricing and Availability

Single-dose vial pricing represents a middle ground in the GLP-1 cost spectrum. Here is how the numbers compare.

Illustration for Glp 1 Single Dose Vials New Option

Brand-name pens remain the most expensive option at $800 to $1,500+ per month without insurance or savings programs. The pen format includes the convenience of a pre-filled, ready-to-use delivery device.

Single-dose vials are priced lower than pens. Exact pricing varies by manufacturer, dose, and pharmacy. The lower cost reflects the removal of the pen device and simplified packaging. Check with your pharmacy or manufacturer for current vial pricing at your prescribed dose.

Patient Perspective: "My insurance denied Wegovy twice. My provider helped me file a peer-to-peer review appeal with supporting documentation from my labs and BMI history. Third time was approved. Don't give up after the first denial.") Brian C., 45, FormBlends patient (name changed for privacy)

Compounded medications from licensed 503A pharmacies typically cost $150 to $400 per month. These contain the same active ingredient, are prescribed by licensed providers, and are prepared per individual prescription. Compounded options remain the most affordable for most people.

Availability of single-dose vials may vary by pharmacy and location. Not all pharmacies stock the vial format immediately. Check with your local pharmacy or mail-order pharmacy for availability. Your provider can also verify options.

Insurance coverage for single-dose vials follows the same rules as pen coverage. Prior authorization requirements, formulary placement, and cost-sharing tiers apply. The vial format may be on a different formulary tier than the pen, potentially resulting in different copays.

For a in-depth look at all pricing options, read our or visit our .

Vials vs. Pens vs. Compounded: Practical Differences

Beyond price, each format has practical pros and cons that affect your daily experience.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.

Try the BMI Calculator →

Convenience: Pre-filled pens are the most convenient. Dial your dose, inject, and dispose. No drawing from a vial required. Single-dose vials require syringe drawing, which adds a few minutes to the process. Compounded vials may be multi-dose (multiple injections per vial), requiring reconstitution and careful measurement.

Dose flexibility: Pens have fixed dose increments set by the manufacturer. Single-dose vials contain one predetermined dose per vial. Compounded medications offer the most dose flexibility since they are prepared per prescription. If your provider wants a non-standard dose, compounded options accommodate that.

Storage: All GLP-1 medications require refrigeration. Pens and single-dose vials are ready to use from the refrigerator. Multi-dose compounded vials need to be used within 4 to 6 weeks after mixing. Single-dose vials eliminate the concern about multi-dose vial contamination since each vial is used once.

Travel friendliness: Pens are the easiest to travel with since they are self-contained. Single-dose vials require you to carry syringes and needles as well. Both need to stay cold during transport. A small insulated travel case works for all formats.

Waste: Single-dose vials create more packaging waste per injection than multi-dose options. Each injection requires a separate vial, syringe, and needle. Multi-dose vials (common with compounded medications) produce less waste per dose.

If you are currently using the to track your doses, it works with any medication format. Log your injections regardless of whether you use pens, vials, or compounded medications.

Who Benefits Most from Single-Dose Vials

Single-dose vials are not the best choice for everyone. Here is who benefits most from this format.

Patients whose insurance covers the vial but not the pen. Some insurance plans place vials and pens on different formulary tiers. If the vial has better coverage on your plan, it could save you significant money compared to the pen format.

People comfortable with syringes. If you already inject peptides or have experience drawing from vials, the syringe process is second nature. The slight inconvenience does not matter to you, and the cost savings are welcome.

Patients who want brand-name medication at a lower price. If you specifically want the brand-name product but find the pen price prohibitive, single-dose vials offer a less expensive version of the same medication.

People in between insurance and compounded options. If you have partial insurance coverage that makes the vial copay affordable, this may be your sweet spot between paying full price for pens and going the compounded route.

Who may prefer other options: If you value maximum convenience, pens are better. If you want the lowest possible price, compounded medications through providers like FormBlends are typically more affordable. If you need custom dosing, compounded options offer more flexibility.

Compare all your options carefully. Run the numbers for your specific insurance situation using our cost comparison tools. Read our for detailed information about the medication itself regardless of format.

Frequently Asked Questions

Are single-dose vials the same medication as the pen?

Yes. Single-dose vials contain the same active ingredient at the same concentration as the pre-filled pen. The only difference is the delivery format. The vial requires you to draw the medication into a syringe, while the pen is pre-filled and ready to inject.

Do I need a different prescription for vials vs. Pens?

Your provider may need to write the prescription specifying the vial format rather than the pen. The medication name and dose remain the same, but the product NDC number differs. Ask your provider to prescribe the specific format you prefer.

Can I use my existing syringes with single-dose vials?

Standard insulin syringes (U-100) work for most GLP-1 single-dose vials. Verify the correct syringe type with your pharmacist based on the specific product you are prescribed. The volume you draw will depend on the medication concentration.

Are single-dose vials available at all pharmacies?

Availability varies. Major retail pharmacies and mail-order pharmacies are most likely to stock single-dose vials. Smaller independent pharmacies may need to special order them. Check with your preferred pharmacy before your provider writes the prescription.

How do single-dose vials compare to compounded medications in cost?

Compounded medications from licensed 503A pharmacies are typically the most affordable option at $150 to $400 per month. Single-dose vial pricing varies but generally falls between compounded and pen pricing. Your total cost depends on insurance coverage, savings programs, and specific dose requirements.

What's Your Next Move?

You have the information. Now let a licensed provider help you put it into action. FormBlends makes it simple (answer a few questions and get a personalized recommendation.


Sources & References

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
  2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
  3. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
  4. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
  5. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
  6. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
  7. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2 (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
  8. Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3 (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
  9. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4 (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
  10. Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
  11. Centers for Disease Control and Prevention. Multistate Outbreak of Fungal Meningitis and Other Infections) United States, 2012. MMWR. 2012;61(41):839-842.
  12. U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). Public Law 113-54. November 27, 2013.

This article is for educational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider before starting, changing, or stopping any medication or supplement. FormBlends connects you with licensed providers who can evaluate your individual health needs.

Last updated: 2026-03-24

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are reviewed by licensed physicians but are not a substitute for a personal medical consultation.

Written by Dr. Sarah Mitchell, MD, FACE

Board-certified endocrinologist specializing in metabolic medicine and GLP-1 therapeutics. Reviewed by Dr. James Chen, PharmD, BCPS, clinical pharmacologist with expertise in compounded medications and peptide therapy.

Ready to get started?

Physician-supervised GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Related Articles

Free Tools

Physician-designed calculators to support your weight loss journey.